G
Genedrive PLC
LSE:GDR
Genedrive PLC
LSE:GDR
Price:
5.375 GBX
-4.44%
Market Closed
Updated:
Apr 29, 2024
Genedrive PLC
Operating Income
|
Genedrive PLC
Operating Income Peer Comparison
Comparables:
ONT
O
ORPH
DXRX
ERGO
HVO
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
G
|
Genedrive PLC
LSE:GDR
|
Operating Income
-£4.9m
|
CAGR 3-Years
7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-10%
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Operating Income
-£168.6m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Operating Income
£6.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Diaceutics PLC
LSE:DXRX
|
Operating Income
£575k
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Ergomed PLC
LSE:ERGO
|
Operating Income
£20.7m
|
CAGR 3-Years
25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Operating Income
£10.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Genedrive PLC's Operating Income?
Operating Income
-4.9m
GBP
-4.9m
GBP
Based on the financial report for Dec 31, 2023, Genedrive PLC's Operating Income amounts to -4.9m GBP.
What is Genedrive PLC's Operating Income growth rate?
Operating Income CAGR 10Y
-10%
-10%
Over the last year, the Operating Income growth was 11%. The average annual Operating Income growth rates for Genedrive PLC have been 7% over the past three years , 8% over the past five years , and -10% over the past ten years .
You don't have any saved screeners yet
